Traders bought shares of Humana Inc. (NYSE:HUM) on weakness during trading on Friday. $253.27 million flowed into the stock on the tick-up and $235.94 million flowed out of the stock on the tick-down, for a money net flow of $17.33 million into the stock. Of all stocks tracked, Humana had the 3rd highest net in-flow for the day. Humana traded down ($4.59) for the day and closed at $158.15

A number of analysts recently commented on HUM shares. Credit Suisse Group AG restated a “hold” rating on shares of Humana in a research report on Tuesday, June 28th. Royal Bank Of Canada upped their price objective on shares of Humana from $209.00 to $220.00 and gave the company a “sector perform” rating in a research report on Thursday, May 5th. Zacks Investment Research cut Humana from a “hold” rating to a “sell” rating in a report on Tuesday, April 12th. Cowen and Company reiterated an “outperform” rating on shares of Humana in a report on Tuesday, April 5th. Finally, Leerink Swann reiterated an “outperform” rating on shares of Humana in a report on Tuesday, June 21st. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $206.00.

The company has a market capitalization of $23.57 billion and a P/E ratio of 22.05. The firm’s 50-day moving average is $180.60 and its 200 day moving average is $175.55.

Humana (NYSE:HUM) last released its earnings results on Wednesday, May 4th. The insurance provider reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.81 by $0.05. During the same quarter in the previous year, the firm earned $2.58 EPS. The firm earned $13.80 billion during the quarter, compared to analyst estimates of $13.80 billion. Humana’s quarterly revenue was down .2% on a year-over-year basis. On average, equities analysts expect that Humana Inc. will post $8.87 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Thursday, June 30th will be issued a $0.29 dividend. The ex-dividend date of this dividend is Tuesday, June 28th. This represents a $1.16 annualized dividend and a yield of 0.73%.

A number of institutional investors have recently added to or reduced their stakes in HUM. Tredje AP fonden raised its position in Humana by 1.7% in the fourth quarter. Tredje AP fonden now owns 9,477 shares of the insurance provider’s stock valued at $1,694,000 after buying an additional 158 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. raised its position in Humana by 1.6% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. now owns 19,095 shares of the insurance provider’s stock valued at $3,409,000 after buying an additional 304 shares during the last quarter. GAM Holding AG raised its position in Humana by 1.5% in the fourth quarter. GAM Holding AG now owns 30,435 shares of the insurance provider’s stock valued at $5,433,000 after buying an additional 444 shares during the last quarter. Comerica Bank raised its position in Humana by 1.3% in the fourth quarter. Comerica Bank now owns 36,810 shares of the insurance provider’s stock valued at $6,365,000 after buying an additional 460 shares during the last quarter. Finally, PNC Financial Services Group Inc. raised its position in Humana by 1.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 42,043 shares of the insurance provider’s stock valued at $7,505,000 after buying an additional 537 shares during the last quarter.

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.